Viedoc Technologies AB
Viedoc Technologies AB
Viedoc Technologies AB (commonly known as Viedoc) is a privately held Swedish company that develops tools for managing clinical trials. Founded in 2003 and headquartered in Uppsala, Sweden, the company provides eClinical tools used by life science organizations to support trial operations, data capture, and regulatory compliance. Since 2019, Viedoc has been majority-owned by the Nordic private equity firm, Monterro.[1].
History
Viedoc was established by clinical research and software professionals. The company initially operated as a contract research organization (CRO) before shifting to a software-focused model in 2005 with the launch of its electronic data capture (EDC) solution.
By 2018, the company had exited its CRO business to develop a cloud-based platform for clinical research. On 11th November 2019, Monterro acquired a majority stake in the company.[2]
Global Presence
Viedoc reports to have offices in: Sweden (headquarters), Japan, China, United States and, Vietnam.
As of 2025, the company employs approximately 140 people worldwide.
Use in Research
Viedoc’s solutions have supported clinical trials across more than 75 countries, including:
- The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial[3]
- Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol[4]
- Confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastases[5]
Compliance and Certifications
Viedoc holds the following certifications and attestations:
- ISO/IEC 27001:2022[6]
- SOC 2 Type 2
- Compliance with GDPR, HIPAA, and 21 CFR Part 11
Partnerships
On July 2, 2025, Viedoc announced a technical integration partnership with PHARMASEAL.[7] Additional strategic partnerships include collaborations with Arkivum, a provider of data archiving solutions[8], and Link Medical[9], a full-service contract research organization (CRO).
Recognition
In 2024 the analyst firm Everest Group listed Viedoc in the ‘Leader’ category in their Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024[10]. This assessment evaluated 20 EDC platform providers based on their capabilities and market impact.
Ownership
Viedoc Technologies AB is majority-owned by Monterro, a Stockholm-based private equity firm. Grev Ture Investments AB, which is part of Monterro, is the legal parent entity.
References
- ↑ "Monterro acquires majority position in PCG Solutions". Mynewsdesk. 2019-11-11. Retrieved 2025-08-13.
- ↑ "Monterro Acquires Viedoc Technologies | Mergr M&A Deal Summary". mergr.com. Retrieved 2025-08-13.
- ↑ Chwiszczuk, Luiza Jadwiga; Breitve, Monica Haraldseid; Kirsebom, Bjørn-Eivind Bordewick; Selnes, Per; Fløvig, John Chr; Knapskog, Anne-Brita; Skogseth, Ragnhild E.; Hubbers, Jessica; Holst-Larsen, Elin; Rongve, Arvid (2023). "The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial". Frontiers in Aging Neuroscience. 15. doi:10.3389/fnagi.2023.1163184. ISSN 1663-4365. PMC 10250712 Check
|pmc=value (help). PMID 37304077 Check|pmid=value (help). Unknown parameter|article-number=ignored (help) - ↑ Yoshihara, Tsutomu; Kessoku, Takaomi; Takatsu, Tomohiro; Misawa, Noboru; Ashikari, Keiichi; Fuyuki, Akiko; Ohkubo, Hidenori; Higurashi, Takuma; Iwaki, Michihiro; Kurihashi, Takeo; Nakatogawa, Machiko; Yamamoto, Koji; Terada, Izuru; Tanaka, Yusuke; Nakajima, Atsushi (December 2022). "Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol". Contemporary Clinical Trials Communications. 30. doi:10.1016/j.conctc.2022.101019. ISSN 2451-8654. PMC 9647338 Check
|pmc=value (help). PMID 36387985 Check|pmid=value (help). Unknown parameter|article-number=ignored (help) - ↑ "Viedoc Technologies achieves ISO/IEC certification for high-quality ISMS - Industry News - Zenopa UK". Zenopa. 2021-08-25. Retrieved 2025-08-13.
- ↑ "Viedoc Technologies achieves ISO/IEC certification for high-quality ISMS - Industry News - Zenopa UK". Zenopa. 2021-08-25. Retrieved 2025-08-13.
- ↑ PHARMASEAL. "PHARMASEAL and Mayet Announce Strategic Integration Partnership". PHARMASEAL. Retrieved 2025-08-13.
- ↑ Lynam, Tom (2025-06-19). "Viedoc Technologies Partnership". Arkivum. Retrieved 2025-08-13.
- ↑ "Full-service CRO LINK Medical and Viedoc™". LINK Medical. 2025-08-04. Retrieved 2025-08-13.
- ↑ "Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024 - Everest Group Research Portal". Retrieved 2025-08-13.
Category:Clinical trials Category:Health informatics Category:Companies established in 2003
This article "Viedoc Technologies AB" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Viedoc Technologies AB. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
